Form D · Other Health Care

Emerging Therapy Solutions, Inc.

Bloomington, MN · CIK 0001763532

Offering snapshot reported Mar 26, 2024 · SEC filing

Reported sold
$5M
Offering amount: $5M
Investors reported
5
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 11, 2024
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 26, 2024Initial$5,000,000No comparison5SEC filing
Dec 20, 2022Initial$3,000,000No comparison5SEC filing
Jun 7, 2021Initial$6,004,725No comparison5SEC filing
Feb 11, 2021Initial$1,000,000No comparison5SEC filing
Feb 18, 2020Initial$2,982,403No comparison5SEC filing
May 22, 2019Initial$1,000,000No comparison1SEC filing
Jan 4, 2019Initial$5,300,000No comparison4SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-508604

Source: Form D, filed Mar 26, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Mike Burke Director
Rob Capone Director
Gary Curtis Director
Ashley Hume Executive
Larry Kocot Director
Steve Lefar Director
Matt Mackowski Director
J. Matthew Mackowski Director
David Mc Lean Director, Executive
Ravi Naliah Director
Ravi Nalliah Director
Kevin Roche Director, Executive
Nathan Schmidt Executive
Jeanette Welsh Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
2001 Killebrew Drive, Ste. 240
Bloomington, MN, 55425